Harmony Biosciences Reports Third-Quarter Revenue of $268.92 Million
Third-quarter 2026 revenue rose 12.3% year over year to $268.92 million, while net income fell 5.2% to $48.2 million and diluted EPS declined 6.9% to $0.81.
Harmony Biosciences Holdings, Inc. reported third-quarter 2026 revenue of $268.92M, up 12.3% from the prior-year quarter, while net income declined 5.2% to $48.2M and diluted EPS fell 6.9% to $0.81.Financial Highlights¹ Reported as “Net product revenue”. ² Reported as “Net income”. ³ Reported as “D…